Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus
Clinical trial NCT02194400 · COMPLETED
Trial details
- NCT number
- NCT02194400
- Sponsor
- Resolve Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2015-11-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.